View More Recent Stories
-
BTIG Reiterates Neutral Rating on Aclaris Therapeutis (ACRS)
-
Aclaris Therapeutics (ACRS) Sells OLUMIANT Royalties and Milestones to OMERS Life Sciences for Up to $31.5M


